{"id":346798,"date":"2026-11-13T17:44:11","date_gmt":"2026-11-13T12:14:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/mk-proteins-q2-results-fy27-pat-0-87-crore\/"},"modified":"2026-11-13T17:44:11","modified_gmt":"2026-11-13T12:14:11","slug":"mk-proteins-q2-results-fy27-pat-0-87-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/mk-proteins-q2-results-fy27-pat-0-87-crore\/","title":{"rendered":"MK Proteins Q2 Results FY27: Revenue Jumps 37.1% to Rs 44.46 Cr, PAT Rs 0.87 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

MK Proteins Q2 Results FY27 were declared on 13 November 2026, and the quarterly results show standalone revenue of Rs 44.46 Cr, up 37.1% from Rs 32.43 Cr a year earlier. Net profit rose 16% to Rs 0.87 Cr from Rs 0.75 Cr, so YoY growth appears on every reported line. These are standalone results for the July to September 2026 quarter.<\/p>\n<\/div>\n

MK Proteins Ltd<\/a> (MKPL) Q2 Results FY27 announced on 13 November 2026, covering the company’s financial performance for the July to September quarter. Revenue stood at Rs 44.46 Cr, Operating Profit at Rs 1.47 Cr and net profit (PAT) at Rs 0.87 Cr, all on a standalone basis. The results date and the standalone results basis frame the numbers below, and MK Proteins Q2 Results FY27 are the headline reference on NSE and BSE.<\/p>\n

This MK Proteins Q2 Results review offers a structured results analysis of the quarter. It walks through the financial highlights, the business factors disclosed with the numbers, the FY27 outlook and the risks to watch, and it begins with the Financial Highlights table that places the latest figures next to the same quarter of last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n